Contact: Vicki Cohn, (914) 740-2156, email@example.com
Articles by Nobel Laureates Sir John Gurdon and Shinya Yamanaka
New Rochelle, NY, October 9, 2012- Mary Ann Liebert, Inc., publishers and the editorial leadership of the peer-reviewed journal Stem Cells and Development congratulate Sir John Gurdon and Shinya Yamanaka on being awarded the Nobel Prize for Physiology or Medicine. Articles by these two distinguished scientists are available free online on the Stem Cells and Development website.
Sir John Gurdon is the corresponding author of an original research report on "Widespread Transcription in an Amphibian Oocyte Relates to Its Reprogramming Activity on Transplanted Somatic Nuclei." Dr. Yamanaka was a coauthor of the article "Generation of Naive-Like Porcine-Induced Pluripotent Stem Cells Capable of Contributing to Embryonic and Fetal Development."
"This joint award is a recognition of the significance of Sir John's breakthrough in our understanding of the potential to produce pluripotent cells from ostensibly mature developed cells in the amphibian,” says Editor-in-Chief Graham C. Parker, PhD, research professor, Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine. “In a delightful ontological recapitulation of stem cells and development, we can trace that seminal work forward to the discovery of Shinya Yamanaka that mammalian cells, including, of course, human, can be re-programmed to pluripotency providing a wonderful in vitro model to advance research in regenerative medicine, in vitro therapeutic testing, cancer research, and of course further our understanding of human development."
About the Journal
Stem Cells and Development is an authoritative peer-reviewed journal that will increase its frequency to 24 times per year beginning in 2013, both print and online. The Journal is dedicated to communication and objective analysis of developments in the biology, characteristics, and therapeutic utility of stem cells, especially those of the hematopoietic system. Complete tables of content and a free sample issue may be viewed online on the Stem Cells and Development website.
About the Publisher
Mary Ann Liebert, Inc. is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cellular Reprogramming, Tissue Engineering, and Human Gene Therapy. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc. website.